210 related articles for article (PubMed ID: 31771404)
1. Pharmacist-Driven Spirometry Screening to Target High-Risk Patients in a Primary Care Setting.
Whitner JB; Mueller LA; Valentino AS
J Prim Care Community Health; 2019; 10():2150132719889715. PubMed ID: 31771404
[No Abstract] [Full Text] [Related]
2. Impact of a Pharmacist-Provided Spirometry Service on Access to Results in a Primary Care Setting.
Mueller LA; Valentino AS; Clark AD; Li J
J Prim Care Community Health; 2018; 9():2150132718759213. PubMed ID: 29468934
[TBL] [Abstract][Full Text] [Related]
3. Pharmacist-managed chronic obstructive pulmonary disease screening in a community setting.
Fuller L; Conrad WF; Heaton PC; Panos R; Eschenbacher W; Frede SM
J Am Pharm Assoc (2003); 2012; 52(5):e59-66. PubMed ID: 22975798
[TBL] [Abstract][Full Text] [Related]
4. Implementation of a pharmacist-led spirometry clinic.
Rutschilling R; Schrader J; Draime JA; Straw A; Barhorst R
J Am Pharm Assoc (2003); 2023; 63(4S):S101-S105. PubMed ID: 36609055
[TBL] [Abstract][Full Text] [Related]
5. Optimizing identification and management of COPD patients - reviewing the role of the community pharmacist.
van der Molen T; van Boven JF; Maguire T; Goyal P; Altman P
Br J Clin Pharmacol; 2017 Jan; 83(1):192-201. PubMed ID: 27510273
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of annual wellness visits provided by pharmacists in an accountable care organization associated with a federally qualified health center.
Alhossan A; Kennedy A; Leal S
Am J Health Syst Pharm; 2016 Feb; 73(4):225-8. PubMed ID: 26843499
[TBL] [Abstract][Full Text] [Related]
7. Establishing Clinical Pharmacy Services With Prescribing Privileges in a Federally Qualified Health Center Primary Care Clinic.
Jun JK
J Pharm Pract; 2018 Oct; 31(5):434-440. PubMed ID: 28718382
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing the acceptance of referrals for clinical pharmacist managed disease states in primary care.
Bhat S; Kroehl M; Yi WM; Jaeger J; Thompson AM; Lam HM; Loeb D; Trinkley KE
J Am Pharm Assoc (2003); 2019; 59(3):336-342. PubMed ID: 30948239
[TBL] [Abstract][Full Text] [Related]
9. Community pharmacy-based case finding for COPD in urban and rural settings is feasible and effective.
Fathima M; Saini B; Foster JM; Armour CL
Int J Chron Obstruct Pulmon Dis; 2017; 12():2753-2761. PubMed ID: 29075108
[TBL] [Abstract][Full Text] [Related]
10. Integration of pharmacists into patient-centered medical homes in federally qualified health centers in Texas.
Wong SL; Barner JC; Sucic K; Nguyen M; Rascati KL
J Am Pharm Assoc (2003); 2017; 57(3):375-381. PubMed ID: 28506398
[TBL] [Abstract][Full Text] [Related]
11. Pharmacist implementation of a transitions of care electronic referral process to provide hand-off between inpatient and outpatient settings.
Martirosov AL; Seitllari K; Kaurala S; MacDonald N
J Am Pharm Assoc (2003); 2020; 60(1):112-116.e1. PubMed ID: 31690512
[TBL] [Abstract][Full Text] [Related]
12. COPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot study.
Castillo D; Guayta R; Giner J; Burgos F; Capdevila C; Soriano JB; Barau M; Casan P;
Respir Med; 2009 Jun; 103(6):839-45. PubMed ID: 19200706
[TBL] [Abstract][Full Text] [Related]
13. A feasibility study of community pharmacists performing depression screening services.
O'Reilly CL; Wong E; Chen TF
Res Social Adm Pharm; 2015; 11(3):364-81. PubMed ID: 25438728
[TBL] [Abstract][Full Text] [Related]
14. The Impact of an Electronic Health Record Intervention on Spirometry Completion in Patients with Chronic Obstructive Pulmonary Disease.
Wang C; Siff J; Greco PJ; Warren E; Thornton JD; Tarabichi Y
COPD; 2022; 19(1):142-148. PubMed ID: 35392743
[TBL] [Abstract][Full Text] [Related]
15. A mixed methods analysis of community pharmacists' perspectives on delivering COPD screening service to guide future implementation.
Fathima M; Saini B; Foster JM; Armour CL
Res Social Adm Pharm; 2019 Jun; 15(6):662-672. PubMed ID: 30131254
[TBL] [Abstract][Full Text] [Related]
16. [Over-diagnosis of chronic obstructive pulmonary disease in Primary Care. Prevalence and determining factors].
Golpe R; Díaz-Fernández M; Mengual-Macenlle N; Sanjuán-López P; Martín-Robles I; Cano-Jiménez E
Semergen; 2017; 43(8):557-564. PubMed ID: 28526439
[TBL] [Abstract][Full Text] [Related]
17. Inpatient pharmacists' patient referrals to a transitions-of-care pharmacist: Evaluation of an automated referral process.
Kerstenetzky L; Heimerl KM; Hartkopf KJ; Hager DR
J Am Pharm Assoc (2003); 2018; 58(5):540-546. PubMed ID: 30017369
[TBL] [Abstract][Full Text] [Related]
18. Promoting Community Pharmacy Practice for Chronic Obstructive Pulmonary Disease (COPD) Management: A Systematic Review and Logic Model.
Hu Y; Yao D; Ung COL; Hu H
Int J Chron Obstruct Pulmon Dis; 2020; 15():1863-1875. PubMed ID: 32821091
[TBL] [Abstract][Full Text] [Related]
19. Follow-up to a federally qualified health center and subsequent emergency department utilization.
Scherer TM; Lewis LM
Acad Emerg Med; 2010 Jan; 17(1):55-62. PubMed ID: 20078437
[TBL] [Abstract][Full Text] [Related]
20. Provider survey of the roles of clinical pharmacists in primary care in a Federally Qualified Health Center versus an Accountable Care Organization.
Amin P; Jones S; Selby C; McCarty J; Smith F; Douglass G
Explor Res Clin Soc Pharm; 2023 Mar; 9():100242. PubMed ID: 37008897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
